Gates Foundation and Flagship Pioneering Launch Collaboration With Up to $25 Million Over Five Years
The Gates Foundation, based in Seattle, Washington, and Flagship Pioneering, a scientific innovation engine based in Cambridge, Massachusetts, announced on Nov. 12 a collaboration to fund the discovery of potential breakthrough health and agricultural solutions to benefit underserved populations in low- and middle-income countries.
The collaboration will leverage Flagship Labs, the company's innovation foundry, along with Flagship's ecosystem of more than 40 breakthrough platform companies spanning human and planetary health, together with the Gates Foundation's deep expertise in global health, women's health, and agriculture. The two organizations aim to identify novel health and agricultural solutions aligned with these priorities and to shorten the path from scientific discovery to products capable of improving lives across low- and middle-income countries.
At the center of the work will be a new initiative operated within Flagship, Pioneering Global Health & Development (PGH&D), led by Dr. Raj Panjabi, Senior Partner. A physician and entrepreneur, Dr. Panjabi has helped lead Flagship's Preemptive Health and Medicine Initiative, is a former White House Senior Director for Global Health Security and Biodefense, and previously led the U.S. President's Malaria Initiative.
The Gates Foundation and Flagship have jointly committed up to $25 million over a five-year period to establish and operate the PGH&D group. Through this work, the organizations aim to identify and initiate a portfolio of programs across global health, women's health, and agriculture, with each program considered for additional funding from both entities for further development.
"The true measure of innovation is not only what it makes scientifically possible, but also how broadly its benefits can reach," said Justine Levin-Allerhand, Executive Partner, Chief Corporate Development Officer and Chief Operating Officer of Flagship Labs. She said that by combining the Gates Foundation's deep understanding of global health, women's health and agricultural innovation needs with Flagship's capacity to originate and develop breakthrough platforms and products, the partners can build access and impact into innovation from the very beginning.
The collaboration builds on Gates Foundation investments of up to $92 million in three Flagship companies: ProFound Therapeutics, Tessera Therapeutics, and Sail Biomedicines, supporting accessible advancements in eclampsia and pre-eclampsia, sickle cell disease and HIV, and malaria, respectively, in service of underserved populations in low- and middle-income countries.
Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, operating with $14 billion of assets under its direction as of its latest capital raise, announced in July 2024. The Gates Foundation is based in Seattle, Washington, and is led by CEO Mark Suzman, under the direction of Bill Gates and its governing board.
(Source: Gates Foundation)
Source: Gates Foundation
Published by GSM · USA (original Chinese edition)
Photo: 盖茨基金会西雅图园区航拍，Sea Cow 摄，CC BY-SA 4.0，经 Wikimedia Commons / Gates Foundation campus in Seattle, aerial view, by Sea Cow, CC BY-SA 4.0, via Wikimedia Commons
